The CFSB Center for Advanced Research, Inc. and Its Private Partners will Provide $50 Million to Expand CFS Biology and Biomedical Technologies for Biomedical Applications

The CFSB Center for Advanced Research, Inc. and Its Private Partners will Provide $50 Million to Expand CFS Biology and Biomedical Technologies for Biomedical Applications

The CFA Center for the Advanced Research and Development of Medical Applications (CARE) will provide $50 million in funding for a new biomedical research and development institute, which will include a facility in CFS and a large-scale research center, according to a release from CARE.

CARE’s proposed center will support research into a variety of topics including biomedicine, medical applications of genomic technology and genomic medicine, the release stated.

CARE was founded in 2014 by Dr. Christopher L. Williams, who previously worked for the NIH.

The institute will have approximately 30 researchers, with more than 100 of those in residence.

CARE will establish a large, research-oriented research and education facility to conduct groundbreaking research, including research on biomedics and biomedical technologies.

The center will be managed by the CFA Research Institute (CREFI), which is an independent private research foundation dedicated to advancing the advancement of biomedical research.

“We are excited to partner with CARE and CFA to build on this important work and explore new avenues for biomedical research,” Dr. William P. Siegel, CFA Director, said in a statement.

“Our goal is to advance the state of the art of research and discovery in biomedical science through a strong and innovative biomedical research infrastructure, which is the key to advancing our nation’s biomedical research agenda.”

CARE has partnered with CFS to establish a new institute in CFA that will be focused on the development of advanced diagnostic and treatment technologies, the statement continued.

CARE has also partnered with the CFS Research Foundation (CFSRF) to establish the Biomedical Advanced Technologies Institute (BITE) that will include the development and commercialization of biomedical technologies and medical devices.

Biomedical advances and cures are becoming more and more important, but there is an urgent need for the development, testing and application of the latest biomedical tools and diagnostics to help people with diseases such as cancer, stroke, diabetes and Alzheimer’s.

The announcement of CARE’s $50M investment came less than a month after CFS filed for bankruptcy protection.

The CFO’s position as the chief operating officer of CFA was previously unknown to the public until the filing of the bankruptcy petition, and CARE’s announcement comes as the CFO is currently under scrutiny by the bankruptcy court.

CFSF announced its bankruptcy filing in February 2016 and it will continue to operate as a separate entity under a new name and a new CEO.

In January, CFS announced that CARE had filed for Chapter 11 bankruptcy protection, with an initial public offering slated for later in the year.

Back to Top